Five Contemporary Drug Launch Phenotypes Every Pharma Marketer Should KnowRead more
Sales and marketing efforts behind a new drug launch can vary significantly by brand and this post highlights five distinct drug launch “phenotypes” observed through transparency data. These case studies are intended to provide an evidence-based perspective on how pharma...
Industry-Sponsored Speaking TrackerRead more
Our tracker provides a monthly summary of fees paid U.S. physicians who have served as a product speaker based on company-reported data.
U.S. Sales Force EstimatorRead more
Our sales force sizing tool provides an annual estimate of deployed resources based on company-reported data.
Lilly’s endocrinology-centric launch of Trulicity into T2DRead more
The Type 2 diabetes (T2D) market is composed of dozens of agents that span a multitude of classes (e.g., GLP-1, SGLT2, and DPP-4) and formulations (e.g., oral and injectable). The conventional way to launch a new agent in T2D relies on a large...
Target specialty mix in prostate cancer: Urology vs. OncologyRead more
While patients with advanced stage cancer are generally treated by hem/oncs or med oncs there are several tumor types that involve specialty areas beyond oncology. In the case of advanced prostate cancer, urologists play a key role in disease management and...